Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Evogene Ltd. AI-powered platform designing life-science solutions for health, ag, and industrial sectors.	Israel	EVGN
Evogene Ltd. AI-powered computational biology developing products for health, agriculture, and industry.	United States of America	EVGN
Evotec SE A drug discovery partner accelerating medicine creation from R&D to manufacturing for pharma/biotech.	United States of America	EVO
EXACT Therapeutics AS Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.	Norway	EXTX
FAN Communications Inc. Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.	Japan	2461
F&M CO.,LTD. Back-office outsourcing & consulting in accounting, finance, and HR for SMEs & sole proprietors.	Japan	4771
Foremost Clean Energy Ltd. Canadian explorer of uranium and lithium for the clean energy sector.	United States of America	FMST
Forte Biosciences, Inc. Clinical-stage biopharma developing FB102 for autoimmune diseases like celiac, vitiligo, & alopecia.	United States of America	FBRX
Fortrea Holdings Inc. Global CRO managing clinical trials for the biopharmaceutical and medical device industries.	United States of America	FTRE
FRIENDLY CORPORATION Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.	Japan	8209